Quick-Med Technologies has announced that the Healthcare Common Procedure Coding System or HSPCS BIOGUARD code was awarded by the Centers for Medicare and Medicaid Services.
Quick-Med Technologies, Inc., is a developer for cutting edge anti-microbial technology for consumer and healthcare markets. These HSPCS codes are a requirement for the reimbursement of Medicare for supplies as well as wound dressings.
The Conforming Bandage of BIOGUARD is the first Conforming type of Bandage that has actions against MRSA microbes, among others. This is currently the only bandage in the market that is designed to protect against cross-contamination as well as infections.
BIOGUARD types of bandages and wound dressings have incorporated the patented Quick Med Nimbus technology. This is the only anti-microbial wound dresser that is non-leaching. NIMBUS almost totally eradicates the pathogens in the BIOGUARD Dressings compared to traditional gauze dressings which act as bacteria incubators. For this reason the high risk of cross contamination that occurs with the old style of gauze dressings is eliminated by the use of BIOGUARD dressings.
J. Ladd Greeno, CEO of Quick-Med Technologies has said that Medicaid and Medicare patients stand for the biggest group of chronically wounded patients. This code from HCPCS is important in the sense that it allows the patient’s practitioners to get reimbursed for BIOGUARD Conforming Bandages. In addition, there is a tendency for private health insurance companies to follow Medicare’s lead in terms of reimbursement for these product classifications.
BIOGUARD Conforming Bandages have been assigned the Code A6266 along with other antimicrobial large roll gauze dressings by BIOGUARD. Medicare uses these HCPCS codes which are monitored by CMS based on the CPT or the Current Procedural Technological codes that the American Medical Association has developed. The company has estimated that the healthcare arenas that depend on HCPCS codes stand for potentially half of the BIOGUARD market’s totality.
At the moment, the antimicrobial dressings market is approximately estimated to be more than two hundred million in the United States. It is also considered one of the most rapidly growing categories inside the $4.1 billion American market for products catering to advanced care for wounds.
In related news, Cisco
teamed up with West Wireless Health Institute on technology and educational initiatives.
Edited by
Marisa Torrieri
